Let’s break the stigma of Vitiligo together. Help us discover potential treatments for Vitiligo by enrolling in our Vitiligo clinical trials.
Vitiligo causes white patches or depigmentation of the skin; it is the most common form of vitiligo. It affects around 0.5% – 2% of the population globally. Vitiligo can occur at any age and affects people of all races and ethnicities. Currently limited Vitiligo treatment options include topical steroids, vitamin D3, calcineurin inhibitors, topical immunomodulators, phototherapy, surgical treatments, and camouflage. MetroBoston is conducting clinical trials in vitiligo to determine the safety and efficacy of new potential treatments that may improve skin pigmentation.
Safety, efficacy, and Tolerability Evaluation
Enroll in our Vitiligo clinical trials near you in Boston and help us untether the complications of Vitiligo.
10-19 Years & Above
Male and Female
Brighton – Boston